F
CELG

FolioMetrix’s Celgene Corp CELG Stock Holding History

FolioMetrix’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$709K Buy
6,626
+1,546
+30% +$177K 0.3% 64
2015
Q1 		$586K Buy
5,080
+279
+6% +$33.3K 0.3% 77
2014
Q4 		$415K Buy
+4,801
New +$506K 0.29% 79

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FolioMetrix's CELG Position: Q2 2015 in Review

FolioMetrix increased its Celgene Corp (CELG) stake by 30% in Q2 2015, buying an estimated $177K and bringing the position to 6,626 shares worth $709K. The position accounts for 0.3% of the portfolio, ranked #64.

FolioMetrix first reported a position in CELG in Q4 2014 and has held it in 3 quarters since. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

  • FolioMetrix held 6,626 shares of Celgene Corp worth $709K as of Q2 2015.
  • FolioMetrix bought 1,546 Celgene Corp shares in Q2 2015, an estimated $177K.
  • Celgene Corp made up 0.3% of FolioMetrix's portfolio in Q2 2015, its #64 holding.
  • FolioMetrix first reported a position in Celgene Corp in Q4 2014 and has held it in 3 quarters since.
  • 1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.